intrapleural minocycline instillation

Phase 3Small molecule

intrapleural minocycline instillation is one of 5 small molecule programs targeting Pneumothorax. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PneumothoraxActive, not recruiting

PneumothoraxPhase 3

Active, not recruiting

Competition

Competitive Landscape

10 competitors in Pneumothorax

#DrugCompanyPhaseTrials

Minocin

Paracetamol

1 3

intrapleural minocycline instillation

NNational Taiwan University Hospital

Phase 3

1 4

Platelet Rich Plasma

ZZagazig University

Phase 1

1 5

Achromycin V

WWyeth-Lederle Vaccines

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pneumothorax1 trial

Additional Minocycline Pleurodesis After Thoracoscopic Procedures for Primary Spontaneous Pneumothorax

Unknown status·NNational Taiwan University Hospital·Phase 3·NCT00154895·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for intrapleural minocycline instillation. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — intrapleural minocycline instillation compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for intrapleural minocycline instillation. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Taiwan University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: NNational Taiwan University Hospital

intrapleural minocycline instillation

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pneumothorax1 trial

References

Drug Info

Quick Facts

Related News